Global P2P Finance Automation Analyst

Ascendis Pharma; Gentofte Kommune; On-site; DKK 480,000 - 600,000; Full time

Job summary

Ascendis Pharma, a global biopharmaceutical company, is seeking a Finance Analyst in Global Finance Operations – Procure to Pay (P2P). The role focuses on automation, digitalization, and process excellence across regional finance systems to optimize vendor accounting, payments, and reporting.

You will partner with Global Finance and IT to enhance ERP usage, data quality, and workflow efficiency while supporting VAT and statistical submissions across European entities.

Qualifications

• Relevant academic degree in Accounting, Finance or related field.
• 2–5 years of experience within Audit, Finance Operations and Accounting.

Responsibilities

• Manage end-to-end vendor accounting including invoices, payments, reconciliations, accruals and close activities with a focus on automation.
• Drive expense management through automation and digital controls to improve employee experience.
• Act as a superuser for ERP systems (Microsoft Dynamics 365 Finance & Operations) and leverage Power Platform, AI tools, and workflow automation.
• Support VAT returns, EC Sales Lists and Intrastat reporting across European jurisdictions.
• Identify scalable improvements across Finance Operations in collaboration with Finance, IT, Tax, and Supply Chain.

Skills

Vendor accounting

Automation

Process optimization

English proficiency

Data analysis

Education

Accounting/Finance degree

Tools

Microsoft Dynamics 365

Power BI

ExFlow

Job description

Ascendis Pharma, a global biopharmaceutical company, is seeking a Finance Analyst in Global Finance Operations – Procure to Pay (P2P). The role focuses on automation, digitalization, and process excellence across regional finance systems to optimize vendor accounting, payments, and reporting.

You will partner with Global Finance and IT to enhance ERP usage, data quality, and workflow efficiency while supporting VAT and statistical submissions across European entities.